Ascendis Pharma A/S

(NASDAQ:ASND)

Latest On Ascendis Pharma A/S (ASND):

Date/Time Type Description Signal Details
2023-05-08 18:47 ESTNewsAscendis Pharma added to Wedbush's best ideas listN/A
2023-05-02 17:38 ESTNewsAscendis Pharma Q1 Earnings: Skytrofa Soars, PTH Hurdles Yet To ClearN/A
2023-05-01 17:06 ESTNewsAscendis' TransCon gets FDA rejection but company hopeful as no new trials requestedN/A
2023-04-28 02:05 ESTNewsAscendis Pharma A/S (ASND) Q1 2023 Earnings Call TranscriptN/A
2023-04-27 01:02 ESTNewsAscendis Pharma Q1 2023 Earnings PreviewN/A
2023-04-20 16:46 ESTNewsAscendis Pharma: A Promising Diversification PlayN/A
2023-04-17 01:29 ESTNewsAscendis Pharma: Recent FDA Setbacks Present A Buying OpportunityN/A
2023-04-06 23:12 ESTNewsAscendis Pharma: Is Dip On TransCon Application A Buy Opportunity?N/A
2023-04-03 14:24 ESTNewsAscendis stock slumps ~35% after FDA finds 'deficiencies' in TransCon applicationN/A
2023-04-03 14:24 ESTNewsAscendis downgraded at Credit Suisse on deficiencies in drug applicationN/A
2023-02-17 11:10 ESTNewsAscendis Pharma A/S (ASND) Q4 2022 Earnings Call TranscriptN/A
2023-02-16 22:05 ESTNewsAscendis Pharma GAAP EPS of -€10.40, revenue of €51.17MN/A
2023-02-15 19:21 ESTNewsAscendis Pharma FY 2022 Earnings PreviewN/A
2023-01-27 16:41 ESTNewsAscendis: Neutral On Skytrofa's Market Launch, Initiating With A Neutral RatingN/A
2023-01-19 02:12 ESTNewsAscendis Pharma: Group's Best Nearby Capital Gain Price-Position StockN/A
2022-11-17 14:37 ESTNewsAscendis, Visen' once-weekly growth hormone drug beats daily hGH in Chinese patients in trialN/A
2022-11-14 19:34 ESTNewsAscendis falls on Phase 2 data for achondroplasia candidateN/A
2022-11-05 05:43 ESTNewsAscendis Pharma A/S (ASND) Q3 2022 Earnings Call TranscriptN/A
2022-11-04 12:46 ESTNewsAscendis Pharma: Translating Valuable IP Into A Profitable BusinessN/A
2022-11-03 02:59 ESTNewsAscendis Pharma GAAP EPS of -€3.03, revenue of €15.29MN/A
2022-11-01 19:43 ESTNewsAscendis Pharma Q3 2022 Earnings PreviewN/A
2022-11-01 03:36 ESTNewsAscendis parathyroid hormone therapy goes under FDA priority reviewN/A
2022-09-16 02:59 ESTNewsAscendis Pharma: TransCon CNP Data Coming Q4N/A
2022-08-31 23:18 ESTNewsAscendis Pharma seeks FDA nod for its parathyroid hormone restorer TransCon PTHN/A
2022-08-11 20:08 ESTNewsAscendis Pharma Q2 results beat buoyed by strong sales of growth hormone drug SkytrofaN/A
2022-08-11 03:38 ESTNewsAscendis Pharma GAAP EPS of -€1.46 beats by €0.69, revenue of €6.16B beats by $6.15BN/A
2022-08-11 03:37 ESTNewsAscendis Pharma A/S (ASND) CEO Jan Mikkelsen on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-10 09:43 ESTNewsAscendis Pharma Q2 2022 Earnings PreviewN/A
2022-08-04 05:34 ESTNewsAscendis Pharma: Institutional Buying Values Dutch Biotech Best-Now Cap-Gain ProspectN/A
2022-05-23 09:02 ESTNewsAscendis, Visen' TransCon hGH meets main goal in growth hormone deficiency China trial in childrenN/A
2022-05-13 04:45 ESTNewsAscendis Pharma slides after Street analysts cut price target over SKYTROFA revenue missN/A
2022-05-12 09:00 ESTNewsAscendis Pharma GAAP EPS of -€2.21 misses by €0.05, revenue of €6.83M beats by €1.98MN/A
2022-05-12 09:00 ESTNewsAscendis Pharma A/S (ASND) CEO Jan Mikkelsen on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-10 19:27 ESTNewsAscendis Pharma Q1 2022 Earnings PreviewN/A
2022-05-09 22:24 ESTNewsAscendis Pharma: Biotech Bear Provides Attractive Entry PointN/A
2022-04-29 17:39 ESTNewsAscendis: Institutional Buying Activity Now Seen As Good Value By Market-MakersN/A
2022-03-25 08:03 ESTNewsAscendis Pharma prices $500.0M convertible senior notes offeringN/A
2022-03-23 22:32 ESTNewsAscendis Pharma slides on offering of $500M convertible senior notesN/A
2022-03-16 20:02 ESTNewsAscendis posts biggest intraday gain in six months as BofA upgrades on trial resultsN/A
2022-03-14 20:55 ESTNewsAscendis Pharma TransCon PTH for hypoparathyroidism meets main goal in phase 3 trialN/A
2022-03-03 04:55 ESTNewsAscendis Pharma GAAP EPS of $7.00 beats by €15.44, revenue of €7.77M misses by $0.13MN/A
2022-03-03 04:55 ESTNewsAscendis Pharma stock falls 7% despite Q4 bottom line beatN/A
2022-03-03 04:55 ESTNewsAscendis Pharma A/S' (ASND) CEO Jan Mikkelsen on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-01 18:03 ESTNewsAscendis Pharma FY Earnings PreviewN/A
2022-01-25 06:13 ESTNewsPfizer/OPKO loss on somatrogon could boost Ascendis Pharma's fortunesN/A
2022-01-24 14:23 ESTNewsAscendis Pharma (ASND) Presents At 40th Annual J.P. Morgan Virtual Healthcare ConferenceN/A
2022-01-24 14:23 ESTNewsPfizer/OPKO loss on somatragon could boost Ascendis Pharma's fortunesN/A
2022-01-14 01:12 ESTNewsAscendis Pharma's TransCon gets EU approval for growth hormone deficiency in childrenN/A
2021-12-30 05:41 ESTNewsAscendis: Danish Biotech With Thin Audience Now Seen As Good Value By Market-MakersN/A
2021-11-19 04:06 ESTNewsPhase 2 data shows durable response of Ascendis candidate for hypoparathyroidismN/A

About Ascendis Pharma A/S (ASND):

Ascendis Pharma A/S, a biopharmaceutical company, develops therapeutics for unmet medical needs. The company develops TransCon growth hormone, which completed Phase III clinical trials for growth hormone deficiency. It also develops TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for achondroplasia. In addition, the company develops preclinical studies in the field of oncology for potential product candidates and evaluate systemic and localized delivery systems using its TransCon technologies. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

See Advanced Chart

General

  • Name Ascendis Pharma A/S
  • Symbol ASND
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 482
  • Fiscal Year EndDecember
  • IPO Date2015-01-28
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.ascendispharma.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 917.83
  • Price/Book (Most Recent Quarter) 8.08
  • Enterprise Value Revenue 1052.08
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$8.67
  • Next Year EPS Estimate -$7.26
  • Next Quarter EPS Estimate -$2.01
  • Return on Assets -25%
  • Return on Equity -58%
  • Earnings Per Share -$5.09
  • Revenue Per Share $0
  • Gross Profit 6.95 million
  • Quarterly Earnings Growth -78.7%
View More

Highlights

  • Market Capitalization 7.87 billion
  • Analyst Target Price $194.63
  • Book Value Per Share $8.43
View More

Share Statistics

  • Shares Outstanding 53.75 million
  • Shares Float 43.76 million
  • % Held by Insiders 3%
  • % Held by Institutions 101.6%
  • Shares Short 2.48 million
  • Shares Short Prior Month 2.21 million
  • Short Ratio 11.66
  • Short % of Shares Outstanding 5%
View More

Technicals

  • Beta 0.79
  • 52 Week High $183.98
  • 52 Week Low $96.24
  • 50 Day Moving Average 152.16
  • 200 Day Moving Average 158.57
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Ascendis Pharma A/S (ASND) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Ascendis Pharma A/S (ASND) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-10$535000-$3.15-$1.87-68.17%
2020-09-302020-11-11$2.76 million-$2.72-$1.87-45.17%
2020-06-302020-08-27$1.44 million-$2.33-$1.61-44.68%
2020-03-312020-05-19$2.23 million-$1.44-$1.41-2.66%
2019-12-312019-12-31$2.51 million-$1.89-$1.62-16.67%
2019-09-302019-11-18$2.44 million-$0.59-$1.2954.34%
2019-06-302019-08-28$3.62 million-$1.38-$1.33-4.4%
2019-03-312019-05-30$6.07 million-$1.38-$1.14-20.89%
2018-12-312018-12-31$12.06 million-$0.86-$1.1424.56%
2018-09-302018-11-28$23153.51-$0.92-$1.1922.87%
2018-06-302018-08-29$20949.72-$0.64-$1.0035.45%
2018-03-312018-05-30$34444.58-$1.25-$0.88-41.8%
2017-12-312018-03-28$362000-$1.13-$0.99-14.12%
2017-09-302017-11-16$546000-$1.22-$0.86-42.4%
2017-06-302017-08-18$533000-$1.11-$0.88-26.09%
2017-03-312017-05-23$398000-$0.87-$0.76-15.03%
2016-12-312017-03-22$855000-$0.55-$0.7122.7%
2016-09-302016-11-30$1.36 million-$0.76-$0.64-19.56%
2016-06-302016-08-31$1.21 million-$0.59-$0.658.96%
2016-03-312016-04-14$1.43 million-$0.59-$0.30-95.13%
2015-09-302015-11-12$2.37 million-$0.29-$0.5648.21%
2015-06-302015-08-24$2.25 million-$0.63-$0.43-46.51%
2015-03-312015-05-18$2.24 million$0.07-$0.39117.95%
2014-12-312015-01-28$2.83 million-$0.65

Ascendis Pharma A/S (ASND) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Ascendis Pharma A/S (ASND) Chart:

Ascendis Pharma A/S (ASND) News:

Below you will find a list of latest news for Ascendis Pharma A/S (ASND) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Ascendis Pharma A/S (ASND) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-09-19750CALL0 0221.64TRUE00
2025-09-19800CALL0 0123.29TRUE00
2025-09-19850CALL0 0112.08TRUE00
2025-09-19900CALL0 0100.96TRUE00
2025-09-19950CALL0 0172.93TRUE00
2025-09-191000CALL0 0161.91TRUE00
2025-09-191050CALL0 089.34TRUE00
2025-09-191100CALL0 081.01TRUE00
2025-09-191150CALL0 0123.21TRUE00
2025-09-191200CALL0 0124.23TRUE00
2025-09-1912563.5CALL0 0115.33TRUE00
2025-09-191300CALL0 061.6TRUE00
2025-09-191350CALL0 091.58TRUE00
2025-09-1914035.5CALL0 152.24TRUE00
2025-09-191450CALL0 048.9TRUE00
2025-09-1915028CALL0 149.96TRUE00
2025-09-1915524.55CALL0 149.39TRUE00
2025-09-1916036.2CALL0 146.44TRUE00
2025-09-1916522.6CALL0 147.16TRUE00
2025-09-1917017.1CALL0 26248.8TRUE00
2025-09-1917514.13CALL0 1047.36TRUE00
2025-09-191807.85CALL0 6846.97TRUE00
2025-09-1918513.8CALL0 34746.06TRUE00
2025-09-1919013.88CALL0 1244.36TRUE00
2025-09-191959.1CALL1 545.27FALSE-2.6-0.22
2025-09-192007.32CALL1 22446.53FALSE7.320
2025-09-192103.68CALL2 1443.37FALSE3.680
2025-09-192201.5CALL0 842.26FALSE00
2025-09-192301.1CALL0 647.48FALSE00
2025-09-192400.5CALL0 15053.95FALSE00
2025-09-192500.8CALL0 160.69FALSE00
2025-09-192600.35CALL0 167.18FALSE00
2025-09-19750PUT0 0193.87FALSE00
2025-09-19800PUT0 0181.87FALSE00
2025-09-19850PUT0 0170.61FALSE00
2025-09-19900PUT0 0160.02FALSE00
2025-09-19950PUT0 0149.99FALSE00
2025-09-191000PUT0 0140.48FALSE00
2025-09-191050PUT0 0131.42FALSE00
2025-09-191100PUT0 0122.76FALSE00
2025-09-191150PUT0 0114.46FALSE00
2025-09-191200PUT0 0106.48FALSE00
2025-09-191251.85PUT0 198.79FALSE00
2025-09-191302.4PUT0 291.36FALSE00
2025-09-191352.6PUT0 184.16FALSE00
2025-09-191403.3PUT0 177.16FALSE00
2025-09-191454.9PUT0 170.72FALSE00
2025-09-191503PUT0 101965.08FALSE00
2025-09-191550.9PUT0 1259.69FALSE00
2025-09-191601PUT0 2155.26FALSE00
2025-09-191651.56PUT0 22949.73FALSE00
2025-09-191702.16PUT0 21548.41FALSE00
2025-09-191752.52PUT1 1542.77FALSE-0.25-0.09
2025-09-191804.2PUT0 152046.54FALSE00
2025-09-191855.05PUT1 1840.54FALSE-0.38-0.07
2025-09-191907.41PUT0 742.07FALSE00
2025-09-1919510.5PUT0 241.19TRUE00
2025-09-1920011PUT0 139.4TRUE00
2025-09-1921018.04PUT0 538.8TRUE00
2025-09-1922033.7PUT0 038.65TRUE00
2025-09-192300PUT0 035.88TRUE00
2025-09-192400PUT0 042.78TRUE00
2025-09-192500PUT0 051.05TRUE00
2025-09-192600PUT0 055.36TRUE00
2025-10-17750CALL0 085.28TRUE00
2025-10-17800CALL0 0145.59TRUE00
2025-10-1785103.5CALL0 0136.16TRUE00
2025-10-17900CALL0 0128.89TRUE00
2025-10-17950CALL0 0120.48TRUE00
2025-10-171000CALL0 064.95TRUE00
2025-10-171050CALL0 062.21TRUE00
2025-10-171100CALL0 053.65TRUE00
2025-10-171150CALL0 030.77TRUE00
2025-10-171200CALL0 052.9TRUE00
2025-10-171250CALL0 078.03TRUE00
2025-10-171300CALL0 078.05TRUE00
2025-10-171350CALL0 044.85TRUE00
2025-10-171400CALL0 045TRUE00
2025-10-171450CALL0 043.76TRUE00
2025-10-171500CALL0 043.57TRUE00
2025-10-1715542.6CALL0 043.55TRUE00
2025-10-171600CALL0 043.35TRUE00
2025-10-171650CALL0 042.61TRUE00
2025-10-1717021.5CALL0 643.1TRUE00
2025-10-171750CALL0 042.12TRUE00
2025-10-1718022CALL0 442.33TRUE00
2025-10-1718519.2CALL0 241.42TRUE00
2025-10-1719015.8CALL0 1540.55TRUE00
2025-10-171959.93CALL0 1040.81FALSE00
2025-10-172009CALL20 37641.85FALSE-1.05-0.1
2025-10-172106.61CALL0 1238.58FALSE00
2025-10-172203.4CALL0 21236.7FALSE00
2025-10-172302.78CALL0 336.29FALSE00
2025-10-172401.5CALL0 439.56FALSE00
2025-10-172501.4CALL0 243.5FALSE00
2025-10-172601.1CALL0 447.96FALSE00
2025-10-17750PUT0 0138.72FALSE00
2025-10-17800PUT0 0130.16FALSE00
2025-10-17850PUT0 0122.13FALSE00
2025-10-17900PUT0 0114.57FALSE00
2025-10-17950PUT0 0107.42FALSE00
2025-10-171000PUT0 0100.64FALSE00
2025-10-171050PUT0 194.18FALSE00
2025-10-171100PUT0 188FALSE00
2025-10-171150PUT0 082.08FALSE00
2025-10-171201.85PUT0 176.77FALSE00
2025-10-171252.45PUT0 271.26FALSE00
2025-10-171302.9PUT0 366.27FALSE00
2025-10-171351.43PUT0 061.4FALSE00
2025-10-171400PUT0 057.2FALSE00
2025-10-171450PUT0 053.74FALSE00
2025-10-171500PUT0 048.56FALSE00
2025-10-171552.49PUT0 145.78FALSE00
2025-10-171600PUT0 043.18FALSE00
2025-10-171654.19PUT0 141.63FALSE00
2025-10-171709.1PUT0 30042.04FALSE00
2025-10-1717510.9PUT0 041.83FALSE00
2025-10-171806.3PUT0 20041.19FALSE00
2025-10-171850PUT0 041.49FALSE00
2025-10-171900PUT0 040.66FALSE00
2025-10-171950PUT0 039.46TRUE00
2025-10-1720016.52PUT0 038.51TRUE00
2025-10-172100PUT0 037.16TRUE00
2025-10-172200PUT0 035.63TRUE00
2025-10-1723051PUT0 135.05TRUE00
2025-10-1724070PUT0 034.15TRUE00
2025-10-172500PUT0 037.44TRUE00
2025-10-172600PUT0 042.05TRUE00
2025-12-19600CALL0 0133.44TRUE00
2025-12-19650CALL0 0125.45TRUE00
2025-12-19700CALL0 068.3TRUE00
2025-12-19750CALL0 1107.54TRUE00
2025-12-19800CALL0 064.68TRUE00
2025-12-19850CALL0 064.66TRUE00
2025-12-19900CALL0 086.8TRUE00
2025-12-19950CALL0 060.3TRUE00
2025-12-191000CALL0 059.58TRUE00
2025-12-1910589CALL0 155.26TRUE00
2025-12-191100CALL0 059.79TRUE00
2025-12-191150CALL0 058.36TRUE00
2025-12-191200CALL0 058.33TRUE00
2025-12-191250CALL0 3856.82TRUE00
2025-12-191300CALL0 156.9TRUE00
2025-12-191350CALL0 156.81TRUE00
2025-12-191400CALL0 355.86TRUE00
2025-12-1914545.54CALL0 255.55TRUE00
2025-12-1915037.5CALL0 255.65TRUE00
2025-12-191550CALL0 054.5TRUE00
2025-12-191600CALL0 6653.94TRUE00
2025-12-1916541CALL0 953.24TRUE00
2025-12-1917035.4CALL0 7152.83TRUE00
2025-12-1917531.9CALL0 552.11TRUE00
2025-12-1918028.8CALL0 8651.14TRUE00
2025-12-1918526.1CALL0 1951.11TRUE00
2025-12-1919023.7CALL0 650.2TRUE00
2025-12-1919521.5CALL0 6149.72FALSE00
2025-12-1920021CALL2 21352.03FALSE1.10.06
2025-12-1921017.9CALL0 8648.03FALSE00
2025-12-1922011.9CALL0 6646.62FALSE00
2025-12-192305CALL0 145.02FALSE00
2025-12-192406CALL0 544.1FALSE00
2025-12-192504.3CALL0 842.62FALSE00
2025-12-192605.3CALL0 941.61FALSE00
2025-12-192702CALL0 540.79FALSE00
2025-12-192801.7CALL0 441.37FALSE00
2025-12-192901.2CALL0 142.7FALSE00
2025-12-19600PUT0 0116.79FALSE00
2025-12-19650PUT0 1109.38FALSE00
2025-12-19700PUT0 0102.56FALSE00
2025-12-19750PUT0 096.23FALSE00
2025-12-19800PUT0 2090.32FALSE00
2025-12-19850PUT0 185.17FALSE00
2025-12-19900PUT0 2180.3FALSE00
2025-12-19950PUT0 175.99FALSE00
2025-12-191000PUT0 172.16FALSE00
2025-12-191052.1PUT0 368.71FALSE00
2025-12-191102.65PUT0 465.55FALSE00
2025-12-191152.5PUT0 162.83FALSE00
2025-12-191203.4PUT0 360.25FALSE00
2025-12-191250PUT0 162.09FALSE00
2025-12-191300PUT0 156.54FALSE00
2025-12-191350PUT0 156.58FALSE00
2025-12-191409.23PUT0 7655.49FALSE00
2025-12-191450PUT0 155.17FALSE00
2025-12-191500PUT0 054.98FALSE00
2025-12-191550PUT0 054.09FALSE00
2025-12-191600PUT0 053.74FALSE00
2025-12-191650PUT0 053.07FALSE00
2025-12-1917011.9PUT0 11552.54FALSE00
2025-12-191750PUT0 051.58FALSE00
2025-12-191800PUT0 050.63FALSE00
2025-12-1918527.5PUT0 16650.48FALSE00
2025-12-191900PUT0 049.79FALSE00
2025-12-1919520.5PUT0 1148.82TRUE00
2025-12-1920030.4PUT0 1748.14TRUE00
2025-12-192100PUT0 146.25TRUE00
2025-12-1922051.9PUT0 346.11TRUE00
2025-12-192300PUT0 044.47TRUE00
2025-12-192400PUT0 142.73TRUE00
2025-12-192500PUT0 041.12TRUE00
2025-12-1926077.4PUT0 040.32TRUE00
2025-12-192700PUT0 041.06TRUE00
2025-12-192800PUT0 042.1TRUE00
2025-12-192900PUT0 045.22TRUE00
2026-01-16750CALL0 063.88TRUE00
2026-01-16800CALL0 060.51TRUE00
2026-01-16850CALL0 054.82TRUE00
2026-01-16900CALL0 057.54TRUE00
2026-01-16950CALL0 056.69TRUE00
2026-01-161000CALL0 055.28TRUE00
2026-01-161050CALL0 054.98TRUE00
2026-01-161100CALL0 053.99TRUE00
2026-01-161150CALL0 053.98TRUE00
2026-01-161200CALL0 053.63TRUE00
2026-01-161250CALL0 053.04TRUE00
2026-01-161300CALL0 053.06TRUE00
2026-01-1613545.5CALL0 152.48TRUE00
2026-01-161400CALL0 052.5TRUE00
2026-01-161450CALL0 052.53TRUE00
2026-01-1615037.5CALL0 052.04TRUE00
2026-01-161550CALL0 051.92TRUE00
2026-01-1616035.98CALL0 651.35TRUE00
2026-01-1616524.85CALL0 2150.94TRUE00
2026-01-1617034.64CALL0 21150.78TRUE00
2026-01-1617525.7CALL0 650.59TRUE00
2026-01-1618035.2CALL0 450.47TRUE00
2026-01-1618529.65CALL1 1750.11TRUE29.650
2026-01-1619025.5CALL0 849.42TRUE00
2026-01-1619522.9CALL0 949.04FALSE00
2026-01-1620023.1CALL1 2150.61FALSE23.10
2026-01-1621013.2CALL0 347.06FALSE00
2026-01-162209.5CALL0 045.36FALSE00
2026-01-1623011.5CALL0 42145.45FALSE00
2026-01-162407.2CALL0 142.98FALSE00
2026-01-162504.83CALL0 342.27FALSE00
2026-01-162600CALL0 040.91FALSE00
2026-01-162700CALL0 040.18FALSE00
2026-01-162802.6CALL0 339.62FALSE00
2026-01-162901.7CALL0 140.49FALSE00
2026-01-16750PUT0 086.9FALSE00
2026-01-16800PUT0 081.59FALSE00
2026-01-16850PUT0 076.95FALSE00
2026-01-16900PUT0 072.56FALSE00
2026-01-16950PUT0 068.68FALSE00
2026-01-161000PUT0 065.24FALSE00
2026-01-161050PUT0 062.37FALSE00
2026-01-161100PUT0 059.29FALSE00
2026-01-161150PUT0 056.85FALSE00
2026-01-161200PUT0 054.88FALSE00
2026-01-161250PUT0 051.95FALSE00
2026-01-161300PUT0 552.58FALSE00
2026-01-161355.23PUT0 2752.44FALSE00
2026-01-161403.78PUT0 1951.34FALSE00
2026-01-161450PUT0 1452.59FALSE00
2026-01-1615010.9PUT0 852.67FALSE00
2026-01-161557.1PUT0 151.66FALSE00
2026-01-1616012.25PUT0 250.89FALSE00
2026-01-161659.58PUT0 3750.3FALSE00
2026-01-1617020.3PUT0 951.07FALSE00
2026-01-1617526.1PUT0 150.77FALSE00
2026-01-161800PUT0 049.66FALSE00
2026-01-1618527.9PUT0 549.22FALSE00
2026-01-1619032.1PUT0 248.65FALSE00
2026-01-1619523.7PUT0 848.17TRUE00
2026-01-1620025.6PUT0 847.77TRUE00
2026-01-162100PUT0 046.08TRUE00
2026-01-162200PUT0 044.8TRUE00
2026-01-162300PUT0 043.79TRUE00
2026-01-162400PUT0 042.25TRUE00
2026-01-162500PUT0 041.3TRUE00
2026-01-162600PUT0 039.79TRUE00
2026-01-162700PUT0 038.84TRUE00
2026-01-162800PUT0 040.14TRUE00
2026-01-162900PUT0 041.71TRUE00
2026-04-171000CALL0 053.15TRUE00
2026-04-171050CALL0 053.87TRUE00
2026-04-171100CALL0 052.99TRUE00
2026-04-171150CALL0 053.52TRUE00
2026-04-171200CALL0 051.76TRUE00
2026-04-171250CALL0 051.45TRUE00
2026-04-171300CALL0 051.3TRUE00
2026-04-171350CALL0 050.93TRUE00
2026-04-171400CALL0 050.67TRUE00
2026-04-171450CALL0 050.11TRUE00
2026-04-171500CALL0 050.36TRUE00
2026-04-171550CALL0 050.04TRUE00
2026-04-171600CALL0 049.89TRUE00
2026-04-171650CALL0 049.56TRUE00
2026-04-171700CALL0 048.99TRUE00
2026-04-1717542.5CALL0 549.31TRUE00
2026-04-171800CALL0 048.22TRUE00
2026-04-171850CALL0 047.98TRUE00
2026-04-171900CALL0 047.44TRUE00
2026-04-171950CALL0 047.12FALSE00
2026-04-172000CALL0 046.6FALSE00
2026-04-172100CALL0 045.55FALSE00
2026-04-172200CALL0 044.88FALSE00
2026-04-172300CALL0 044.13FALSE00
2026-04-172400CALL0 043.07FALSE00
2026-04-172500CALL0 042.36FALSE00
2026-04-172600CALL0 041.92FALSE00
2026-04-172700CALL0 041.24FALSE00
2026-04-172800CALL0 040.93FALSE00
2026-04-172905.1CALL0 140.35FALSE00
2026-04-171000PUT0 054.73FALSE00
2026-04-171050PUT0 053.08FALSE00
2026-04-171102.15PUT1 051.59FALSE2.150
2026-04-171152.7PUT1 051.24FALSE2.70
2026-04-171200PUT0 049.93FALSE00
2026-04-171250PUT0 050.03FALSE00
2026-04-171300PUT0 050.11FALSE00
2026-04-171350PUT0 050.07FALSE00
2026-04-171400PUT0 050.08FALSE00
2026-04-171450PUT0 050.11FALSE00
2026-04-171500PUT0 049.67FALSE00
2026-04-171550PUT0 049.2FALSE00
2026-04-171600PUT0 049.41FALSE00
2026-04-171650PUT0 048.81FALSE00
2026-04-171700PUT0 048.37FALSE00
2026-04-171750PUT0 048.06FALSE00
2026-04-171800PUT0 047.78FALSE00
2026-04-171850PUT0 047.61FALSE00
2026-04-171900PUT0 047.05FALSE00
2026-04-171950PUT0 046.61TRUE00
2026-04-172000PUT0 046.11TRUE00
2026-04-172100PUT0 045.32TRUE00
2026-04-172200PUT0 044.51TRUE00
2026-04-172300PUT0 043.54TRUE00
2026-04-172400PUT0 042.48TRUE00
2026-04-172500PUT0 041.46TRUE00
2026-04-172600PUT0 040.55TRUE00
2026-04-172700PUT0 039.97TRUE00
2026-04-172800PUT0 039.65TRUE00
2026-04-172900PUT0 038.63TRUE00
2026-06-18800CALL0 057.66TRUE00
2026-06-18850CALL0 057.31TRUE00
2026-06-18900CALL0 054.56TRUE00
2026-06-18950CALL0 053.67TRUE00
2026-06-181000CALL0 052.5TRUE00
2026-06-181050CALL0 052.43TRUE00
2026-06-181100CALL0 053.01TRUE00
2026-06-181150CALL0 053.03TRUE00
2026-06-181200CALL0 052.66TRUE00
2026-06-181250CALL0 052TRUE00
2026-06-181300CALL0 051.81TRUE00
2026-06-181350CALL0 051.33TRUE00
2026-06-181400CALL0 1051.22TRUE00
2026-06-181450CALL0 050.84TRUE00
2026-06-181500CALL0 050.24TRUE00
2026-06-1815551.5CALL0 250.42TRUE00
2026-06-1816049CALL0 249.43TRUE00
2026-06-1816536.9CALL0 249.18TRUE00
2026-06-1817037CALL0 1048.74TRUE00
2026-06-1817545.2CALL0 148.94TRUE00
2026-06-1818040.44CALL0 948.14TRUE00
2026-06-1818531.8CALL0 147.97TRUE00
2026-06-1819025.6CALL0 547.62TRUE00
2026-06-1819536.2CALL0 247.48FALSE00
2026-06-1820025.8CALL0 346.82FALSE00
2026-06-1821025CALL0 1545.79FALSE00
2026-06-1822020.6CALL0 244.89FALSE00
2026-06-1823018.6CALL0 443.79FALSE00
2026-06-182400CALL0 043.22FALSE00
2026-06-1825013.5CALL0 142.65FALSE00
2026-06-182600CALL0 041.71FALSE00
2026-06-182700CALL0 041.33FALSE00
2026-06-182800CALL0 040.56FALSE00
2026-06-182900CALL0 040.36FALSE00
2026-06-18800PUT0 063.57FALSE00
2026-06-18850PUT0 056.47FALSE00
2026-06-18900PUT0 058.17FALSE00
2026-06-18950PUT0 053.88FALSE00
2026-06-181000PUT0 051.72FALSE00
2026-06-181050PUT0 052.32FALSE00
2026-06-181100PUT0 051.76FALSE00
2026-06-181150PUT0 052.05FALSE00
2026-06-181200PUT0 052.13FALSE00
2026-06-181250PUT0 051.98FALSE00
2026-06-181309.08PUT0 051.65FALSE00
2026-06-181350PUT0 051.18FALSE00
2026-06-181400PUT0 051.18FALSE00
2026-06-181450PUT0 049.69FALSE00
2026-06-1815016.25PUT0 250.36FALSE00
2026-06-1815522.5PUT0 149.93FALSE00
2026-06-1816018.98PUT0 249.21FALSE00
2026-06-1816525.21PUT0 249.19FALSE00
2026-06-1817025.05PUT0 248.53FALSE00
2026-06-1817526.3PUT0 4448.52FALSE00
2026-06-1818033.3PUT0 947.91FALSE00
2026-06-1818535.6PUT0 847.52FALSE00
2026-06-181900PUT0 046.95FALSE00
2026-06-1819530.4PUT0 146.6TRUE00
2026-06-1820044.5PUT0 246.07TRUE00
2026-06-1821038.5PUT0 145.25TRUE00
2026-06-182200PUT0 044.51TRUE00
2026-06-182300PUT0 043.55TRUE00
2026-06-182400PUT0 042.52TRUE00
2026-06-182500PUT0 042.08TRUE00
2026-06-1826090.48PUT0 26941.4TRUE00
2026-06-182700PUT0 040.41TRUE00
2026-06-182800PUT0 039.59TRUE00
2026-06-182900PUT0 039.09TRUE00

Latest ASND Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$79.93
Jun 13, 2022 7:59 PM EST4$79.91
Jun 13, 2022 7:59 PM EST118$79.93
Jun 13, 2022 7:59 PM EST9$79.97
Jun 13, 2022 7:59 PM EST17$79.97

Ascendis Pharma A/S (ASND) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520185199/0001193125-20-185199-index.htm
2019-06-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000008025519002847/0000080255-19-002847-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000008025520001284/0000080255-20-001284-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000031506620000822/0000315066-20-000822-index.htm
2019-03-12SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787119000203/0000947871-19-000203-index.htm
2019-08-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787119000594/0000947871-19-000594-index.htm
2020-03-05SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000185/0000947871-20-000185-index.htm
2020-05-08SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000446/0000947871-20-000446-index.htm
2020-05-22SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000511/0000947871-20-000511-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920021751/0001104659-20-021751-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920021912/0001104659-20-021912-index.htm
2020-09-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920103962/0001104659-20-103962-index.htm
2019-02-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519042416/0001193125-19-042416-index.htm
2019-03-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519059442/0001193125-19-059442-index.htm
2019-03-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519061604/0001193125-19-061604-index.htm
2019-03-04424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519062499/0001193125-19-062499-index.htm
2019-03-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519065750/0001193125-19-065750-index.htm
2019-03-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519069120/0001193125-19-069120-index.htm
2019-03-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519074983/0001193125-19-074983-index.htm
2019-04-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519096618/0001193125-19-096618-index.htm
2019-04-0320-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519096759/0001193125-19-096759-index.htm
2019-04-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519105316/0001193125-19-105316-index.htm
2019-04-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519112380/0001193125-19-112380-index.htm
2019-05-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519133019/0001193125-19-133019-index.htm
2019-05-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519149447/0001193125-19-149447-index.htm
2019-05-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519161327/0001193125-19-161327-index.htm
2019-05-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519161365/0001193125-19-161365-index.htm
2019-06-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519173846/0001193125-19-173846-index.htm
2019-06-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519175289/0001193125-19-175289-index.htm
2019-06-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519181943/0001193125-19-181943-index.htm
2019-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519187411/0001193125-19-187411-index.htm
2019-07-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519191873/0001193125-19-191873-index.htm
2019-07-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519196527/0001193125-19-196527-index.htm
2019-08-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519221217/0001193125-19-221217-index.htm
2019-08-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519232458/0001193125-19-232458-index.htm
2019-09-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519244911/0001193125-19-244911-index.htm
2019-09-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519255970/0001193125-19-255970-index.htm
2019-10-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519263919/0001193125-19-263919-index.htm
2019-10-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519265843/0001193125-19-265843-index.htm
2019-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519292336/0001193125-19-292336-index.htm
2019-11-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519293431/0001193125-19-293431-index.htm
2019-11-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519294735/0001193125-19-294735-index.htm
2019-12-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519312728/0001193125-19-312728-index.htm
2020-01-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520002169/0001193125-20-002169-index.htm
2020-01-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520005786/0001193125-20-005786-index.htm
2020-01-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520008093/0001193125-20-008093-index.htm
2020-02-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520033240/0001193125-20-033240-index.htm
2020-03-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520071551/0001193125-20-071551-index.htm
2020-03-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520092940/0001193125-20-092940-index.htm
2020-04-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520094591/0001193125-20-094591-index.htm
2020-04-0320-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520096870/0001193125-20-096870-index.htm
2020-04-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520108208/0001193125-20-108208-index.htm
2020-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520111593/0001193125-20-111593-index.htm
2020-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520112279/0001193125-20-112279-index.htm
2020-04-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520126717/0001193125-20-126717-index.htm
2020-05-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520133706/0001193125-20-133706-index.htm
2020-05-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520142982/0001193125-20-142982-index.htm
2020-05-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520146167/0001193125-20-146167-index.htm
2020-06-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520157336/0001193125-20-157336-index.htm
2020-06-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520167815/0001193125-20-167815-index.htm
2020-06-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520180048/0001193125-20-180048-index.htm
2020-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520185199/0001193125-20-185199-index.htm
2020-07-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520187456/0001193125-20-187456-index.htm
2020-07-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520187810/0001193125-20-187810-index.htm
2020-07-09424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520190428/0001193125-20-190428-index.htm
2020-07-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520191149/0001193125-20-191149-index.htm
2020-07-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520194325/0001193125-20-194325-index.htm
2020-08-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520219118/0001193125-20-219118-index.htm
2020-08-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520233148/0001193125-20-233148-index.htm
2020-09-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520241091/0001193125-20-241091-index.htm
2020-09-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520243078/0001193125-20-243078-index.htm
2020-09-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520252366/0001193125-20-252366-index.htm
2020-09-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520257235/0001193125-20-257235-index.htm
2020-09-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520257292/0001193125-20-257292-index.htm
2020-10-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520263856/0001193125-20-263856-index.htm
2020-10-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000119312520265872/0001193125-20-265872-index.htm
2020-10-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520270385/0001193125-20-270385-index.htm
2020-10-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520275018/0001193125-20-275018-index.htm
2019-10-23SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000121390019020915/0001213900-19-020915-index.htm
2019-02-22CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1612042/999999999719000498/9999999997-19-000498-index.htm
2020-07-15CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1612042/999999999720004106/9999999997-20-004106-index.htm